logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
H

Hui Jing

Chengdu University of Traditional Chinese Medicine
H指数:17
被引数:979

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Conversion Surgery After Induction Therapy for Initially Unresectable Stage III Non-small Cell Lung Cancer: A Proof-of-Concept Trial

诱导治疗后可切除的初始不可切除III期非小细胞肺癌的转化手术：一项概念验证试验

Annals of Surgical Oncology
IF3.5
2026-03-010
OA
Yan, Yan; Han, Yichao; Niu, Zhenyi; Zhang, Xianfei; Li, Chengqiang; Cao, Yuqin; Yin, Zhengxin; Zhu, Lianggang; Hang, Junbiao; Che, Jiaming; Ren, Jian; Xiang, Jie; Chen, Kai; Du, Hailei; Han, Dingpei; Yang, Xiaoqing; Zhang, Yajie; Chen, Xueyu; Jing, Hui; Yu, Shengjia; Wang, Xiaofeng; Guo, Zengya; Chen, Xiaoyan; Luo, Fangxiu; Zhong, Wenzhao; Jin, Runsen; Li, Hecheng
Preoperative pembrolizumab (anti-PD-1 antibody) combined with chemoradiotherapy for esophageal squamous cell carcinoma: a phase 1/2 trial (PALACE-2)

术前pembrolizumab (anti-PD-1抗体) 联合放化疗治疗食管鳞癌1/2期临床试验 (PALACE-2)

Signal Transduction and Targeted Therapy
IF52.7
2025-11-280
OAAI
Chengqiang Li; Yichao Han; Shengguang Zhao; Xiaozheng Kang; Yuyan Zheng; Yuqin Cao; Yan Yan; Liqiang Shi; Xipeng Wang; Tong Lu; Guowen Zou; Huan Li; Jiaming Che; Jie Xiang; Lianggang Zhu; Junbiao Hang; Yajie Zhang; Runsen Jin; Dingpei Han; Xueyu Chen; Hui Jing; Wei Guo; Zenghui Cheng; Liqin Zhao; Xiaoyan Chen; Bentong Yu; Jian Li; Bin Li; Yin Li; Hecheng Li
Neoadjuvant camrelizumab combined with chemoradiotherapy and watch-and-wait strategy versus neoadjuvant chemoradiotherapy followed by surgery in locally advanced oesophageal squamous cell carcinoma: study protocol of a randomised controlled trial (PALACE-3)

新辅助卡瑞利珠单抗联合化放疗与观察等待策略 versus 新辅助化放疗后手术在局部晚期食管鳞状细胞癌中的应用：一项随机对照试验的研究方案（PALACE-3）

BMJ OPEN
IF2.3
2025-10-150
OA
Wang, Xipeng; Li, Chengqiang; Cao, Yuqin; Kang, Xiaozheng; Leng, Xuefeng; Zheng, Yan; Zheng, Bin; Guo, Wei; Jing, Hui; Han, Yongtao; Chen, Chun; Li, Yin; Li, Hecheng

研究方向

暂未获取到该数据
何
何晓敏
H 指数:28论文数:137被引数:3,690
高
高亚军
H 指数:21论文数:95被引数:1,741
A
Ayub Atif
H 指数:5论文数:11被引数:122
郑
郑景浩
H 指数:18论文数:108被引数:1,488
H
Hui Tian
H 指数:18论文数:52被引数:1,115
H 指数:0论文数:38被引数:295
H 指数:0论文数:17被引数:72
Z
Zhongqun Zhu
H 指数:18论文数:83被引数:1,295
X
Xiaoyang Zhang
H 指数:39论文数:213被引数:8,994
C
Chengqiang Li
H 指数:19论文数:98被引数:1,386